Adverse Events FDA received an adverse event report on January 14, 2019, regarding seven patients in an outpatient clinic who received intravenous injections containing L-glutathione 200mg/mL compounded by a pharmacy using L-glutathione repackaged by Letco (lot number: 1810150050, expiration date: 6/17/2020)
Biomed Mater 18, 035004.CrossRefGoogle Scholar Ballatori, N, Krance, SM, Marchan, R, et al
Peng, C
"If you go that route, the smart move is to do it with a qualified provider, since dosing is not standardized and, while reactions are uncommon, it is a medical treatment, not a casual add-on." Are There Downsides to Taking Glutathione
PMID: 38873418 Simple diagnostic test using GH-releasing peptide-2
These injections are not approved by the FDA and are often unregulated